evden eve nakliyatsehirlerarasi evden eve nakliyat

News

A 5-year financing to support Alexey Pshezhetsky's leading program in glycomics

A 5-year financing to support Alexey Pshezhetsky's leading program in glycomicsThe Networks of Centers of Excellence of Canada announced on February 6, 2015, that its newly selected national research network GlycoNet was receiving $27.3 million over five years to develop new drugs and vaccines for conditions such as influenza, genetic diseases and diabetes, building on Canada's international leadership in glycomics.
Lire la suite...
 

Sébastien Jacquemont is in Montreal to study the genetic origins of autism

Sébastien Jacquemont is in Montreal to study the genetic origins of autism

The geneticist Sébastien Jacquemont is the new holder of the Canada Research Chair in Genetics of Ne...

Lire la suite...

Latest advences in perinatal research

Latest advences in perinatal research

CHU Sainte-Justine, a leader in mother-child health research affiliated to Université de Montréal, i...

Lire la suite...

Maryse and William Brock Chair in Applied Stem-Cell Transplant Research to be created at UdeM

Maryse and William Brock Chair in Applied Stem-Cell Transplant Research to be created at UdeMA new chair of applied research on stem-cell transplants will soon be created at the Université de M...
Lire la suite...

An important scientific breakthrough by Michel Cayouette's team in the fight against blindness

An important scientific breakthrough by Michel Cayouette's team in the fight against blindnessA team of researchers at the IRCM led by Michel Cayouette, PhD, identified one of the genes responsi...
Lire la suite...
Page 1 sur 205

Dossiers

 

Au-delà du 8 mars...

Une journée pour souligner les réalisations des femmes, c’est bien beau, mais qu’en ...

 

L'autisme

Vivre avec un trouble du spectre de l'autisme n'est pas une sinécure. Mais, grâce aux av...

Le chiffre

40 %

C'est le pourcentage d'étudiants canadiens qui terminent leurs études universitaires sans aucune dette.

Lire la suite...